Therapeutic Classification: lipid-lowering agents
Pharmacologic Classification: microsomal transfer protein inhibitors
REMS
Absorption: 7% absorbed following oral administration.
Distribution: Unknown.
Protein Binding: 99.8%.
Half-Life: 39.7 hr
Contraindicated in:
Use Cautiously in:
Drug-drug:
Drug-Natural Products:
Lab Test Considerations:
Lomitapide is only available from health care professionals and pharmacies called the Juxtapid REMS Program because of risk of hepatotoxicity. Information is available at www.JUXTAPIDREMSProgram.com or by calling 1-855-JUXTAPID (1-855-898-2743).